Safe therapy of osteoarthritis: place of topical nonsteroidal anti-inflammatory drugs
Open Access
- 16 July 2020
- journal article
- research article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 128-134
Abstract
The article discusses the social significance of osteoarthritis as a widespread disease that develops mainly in older people, which makes it difficult to carry out anti-inflammatory and analgesic therapy due to the frequent combination of osteoarthritis with other diseases at this age, the need to treat comorbid conditions, which is often poorly combined with systemic therapy with non-steroidal anti-inflammatory drugs. It is noted that osteoarthritis not only worsens the quality of life of patients, but also leads to a decrease in the length of their life, which emphasizes the medical and social importance of conducting the safest possible therapy for this disease. Data on the negative impact of the presence of chronic pain on the progression of osteoarthritis are presented. The negative aspects of the use of oral forms of non-steroidal anti-inflammatory drugs are discussed: the development of adverse events primarily from the gastrointestinal tract and cardiovascular system, the negative effect on the synthesis of glycoaminoglycans («chondronegative effect»). Discusses the place of topical forms of NSAIDs in the treatment of patients with osteoarthritis in accordance with the recommendations of the International society for the use of topical forms of NSAIDs in the management of patients with osteoarthritis of large and small joints. Data on transdermal transport of the topical form of diclofenac, a small molecule with lipophilic properties, are presented. Data on the effectiveness of topical forms of diclofenac in comparison with oral forms are presented according to numerous randomized controlled trials, and the comparable effectiveness of both forms of diclofenac is demonstrated, with maximum safety of the topical form. A special structure of Voltaren® Emulgel (Voltaren® Emulgel), combining the properties of a gel and cream, which provides rapid transdermal penetration and longer retention of the active substance in the area of inflammation, is described, as well as a special prolonged form of Voltaren® Emulgel), which creates additional convenience for use.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Acute Ankle SprainMedicine & Science in Sports & Exercise, 2012
- All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort studyBMJ, 2011
- Prevalence of Hip Symptoms and Radiographic and Symptomatic Hip Osteoarthritis in African Americans and Caucasians: The Johnston County Osteoarthritis ProjectThe Journal of Rheumatology, 2009
- Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamineCurrent Medical Research and Opinion, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerabilityCurrent Medical Research and Opinion, 2007
- Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by useContact Dermatitis, 2006
- Prevalence of Symptomatic Hand Osteoarthritis and Its Impact on Functional Status among the Elderly: The Framingham StudyAmerican Journal of Epidemiology, 2002
- Topisches Diclofenac Emulgel versus orales Ibuprofen in der Therapie der aktivierten Arthrose der Fingergelenke (Heberden- und/oder Bouchard-Arthrose) - Doppelblinde, kontrollierte, randomisierte Studie -Aktuelle Rheumatologie, 2001
- Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilageBritish Journal of Pharmacology, 2000